期刊文献+

羟苯氨酮对离体鼠心停灌-复灌损伤的保护作用 被引量:2

Protection of oxyphenamone against cardiac arrest-reperfusion injury of isolated rat hearts
下载PDF
导出
摘要 目的研究羟苯氨酮对全心停灌复灌损伤的影响。方法采用离体大鼠心脏停灌40min复灌30min模型,从心脏功能、心肌能量代谢、抗氧化、线粒体钙超载及超微结构等方面观察药物作用。结果停灌前和复灌时给予羟苯氨酮(1~10μmol·L-1)明显增加复灌时心肌收缩力与冠脉流量,降低冠脉流出液的肌酸磷酸激酶(CPK)活性,对抗损伤所致的心肌三磷酸腺苷(ATP)与磷酸肌酸(PCr)含量降低,增强心肌抗氧化能力,对抗线粒体钙超载,使线粒体超微结构保持得比较完整。结论羟苯氨酮明显对抗停灌复灌致心肌损伤,为该药保护再灌注损伤提出有力依据。 Aim To ascertain the protective effect of oxyphenamone, a novel inodilator, against myocardial ischemia-reperfusion injury. Methods A model of global myocardial isehemia-reperfusion injury (I-R) was established by arresting the infusion to heart 40 min followed by reperfusion 30 min in the preparations of rat Langendorff' s hearts. The protective effects of oxyphenamone were evaluated by the cardiac function, the activity of creatine phosphokinase (CPK) in coronary efflux, the myocardial energy metabolism and antioxidation, the membrane fluidity, the activity of ATPase, the calcium content and ultrastructure of mitochondria. Results Administration of oxyphenamone to the infused heart before cardiac arrest and during reperfusion ameliorated the decreases of myocardial contractile force and coronary flow and the increase of the activity of CPK in coronary efflux induced by cardiac arrest-reperfusion ( A-R). At the concentration of 1-10 μmol· L^-1 oxyphenamone dose-dependently antagonized the decrease of myocardial adenosine triphosphate (ATP) and creatine phosphate (PCr) induced by A-R, increased the activities of myocardial superoxide dismutase ( SOD ) and glutathione peroxidase ( GSH-px ) , decreased mitochondrial malondialdehyde (MDA) content and increased membrane fluidity, tglutathione (GSH) content and the activities of GSH-px and ATP-ase of mitochondria. The parameters mentioned above even maintained at normal level when high concentration of oxyphenamone (10 μmol·L^-1) was applied. Oxyphenamone also antagonized the mitochondrial calcium overload and the ultrastructure damage of mitochondria induced by A-R obviously. Addition of oxyphenamone (1-100 μmol·L^-1) to the system of Fe^2+-cysteine or Fe^2+-H2O2, which could produce oxygen free radicals, decreased MDA content and increased GSH and membrane fluidity of mitochondria significantly. Conclusion With the reasults of examinations of the cardeac physiological function, myocardial energy metabolism and antioxidation and the calcium content and ultrastructure of mitochondria, it is indicated that oxyphenamone could protect the isolated rat heart against cardiac arrest-reperfusion injury markedly and the mechanism of its action may be related to the antioxidative effect of this agent.
机构地区 中国医学科学院
出处 《药学学报》 CAS CSCD 北大核心 2005年第8期705-710,共6页 Acta Pharmaceutica Sinica
基金 国家科技部新药基金项目(9690105122).
关键词 羟苯氨酮 心脏停灌-复灌 线粒体 心肌能量代谢 抗氧化 钙超载 oxyphenamone cardiac arrest-reperfusion mitochondria myocardial energy metabolism antioxidation calcium overload
  • 相关文献

参考文献4

二级参考文献24

  • 1范礼理,孙卓前,宋珍,滕健,林勇.羟苯氨酮对心肌生理特性及细胞内游离钙的影响[J].中国药学杂志,2005,40(3):186-189. 被引量:6
  • 2范礼理,马军,王亚芳,阮英茆,曾宪可.羟苯氨酮对实验性心肌缺血的治疗作用[J].药学学报,2005,40(2):122-126. 被引量:5
  • 3滕健 范礼理.新型强心药氨基酮类化合物对心肌细胞内[Ca^2+]与“钙敏感性”的影响[J].中国病理生物杂志,1996,12:733-733.
  • 4范礼理 O'keefe DD.葛根素对急性心肌缺血狗区域性心脏血流动力学的作用[J].药学学报,1984,19:801-801.
  • 5吕富华.磷酸二酯酶抑制剂类变力药的研究近况[J].国外医学:药学分册,1987,3:148-148.
  • 6范礼理 陈维洲 等.收缩蛋白对Ca^2+的敏感性与“钙增敏剂”的研究.心血在管药理学进展[M].北京:人民卫生出版社,1995.251-263.
  • 7邵国贤 范礼理 等.氨基酮类化合物的制备方法[J].发明专利公报,1991,7:27-27.
  • 8陈修 陈维洲 曾贵云.心血管药理(第3版)[M].北京:人民卫生出版社,2002.491.
  • 9Moiseyev VS, Poder P, Andrejevs N, etal. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction[J]. Eur Heart J,2002,23:1422.
  • 10Stemmer P, Akera T, Brody TM, et al. Isolation and enrichment of Ca2 +-tolerant myocytes for biochemical experiments from guinea pig heart[J]. Life Sci, 1989, 44: 1231.

共引文献22

同被引文献18

  • 1范礼理,孙卓前,宋珍,滕健,林勇.羟苯氨酮对心肌生理特性及细胞内游离钙的影响[J].中国药学杂志,2005,40(3):186-189. 被引量:6
  • 2范礼理,马军,王亚芳,阮英茆,曾宪可.羟苯氨酮对实验性心肌缺血的治疗作用[J].药学学报,2005,40(2):122-126. 被引量:5
  • 3范礼理,滕健,张润东,赵德育.羟苯氨酮保护大鼠心脏对抗心肌缺血-再灌注损伤[J].药学学报,2005,40(6):507-512. 被引量:13
  • 4范礼理,马军,李华,王亚芳,曾宪可.羟苯氨酮保护麻醉猫心对抗缺血与再灌注损伤[J].基础医学与临床,2006,26(4):349-355. 被引量:3
  • 5刘海波.心肌缺血-再灌注损伤[A].见:陈在嘉 高润霖 主编.冠心病[C].北京:人民卫生出版社,2002.919-930.
  • 6Podesser BK,Schirnhofer J,Bernecker OY,et al.Optimizing ischemia/reperfusion in the failing rat heart-improved myocardial protection with acute ACEI inhibition[J].Circulation,2002,106(12 Suppl 1):I277-283.
  • 7Masereel B,Pochet L,Laeckmann D.An overview of inhibitors of Na(+)/H(+) exchanger[J].Eur J Med Chem,2003,38 (6):547-554.
  • 8LILLEBERG J,NIEMINEN MS,AKKILA J,et al.Effects of a new calcium sensitizer,levosimendan,on haemodynamics,coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting[J].Eur Heart J,1998,19(4):660-668.
  • 9MOISEYEV VS,PODER P,ANDREJEVS N,et al.Safety and efficacy of a novel calcium sensitizer,levosimendan,in patients with left ventricular failure due to an acute myocardial infarction[J].Eur Heart J,2002,23(18):1422-1432.
  • 10TOLLER WG,STRRANZ C.Levosimendan,a new inotropic and vasodilator agent[J].Anesthesiology,2006,104 (3):556 -569.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部